Palomino Laboratories Inc.

Company Information

Industry Blank Checks
SIC Code 6770
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 12 E. 49TH STREET, NEW YORK, NY, 10017
Mailing Address 12 E. 49TH STREET, NEW YORK, NY, 10017
Phone (917) 200-3734
Fiscal Year End 1231
EIN 881619619

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 31, 2026 View on SEC
S-1 IPO registration statement January 23, 2026 View on SEC
10-Q Quarterly financial report November 14, 2025 View on SEC
8-K Current report of material events October 30, 2025 View on SEC
SCHEDULE 13D Beneficial ownership report (>5%) October 27, 2025 View on SEC
4 Insider stock transaction report October 27, 2025 View on SEC
4 Insider stock transaction report October 9, 2025 View on SEC
4 Insider stock transaction report October 9, 2025 View on SEC
4 Insider stock transaction report October 9, 2025 View on SEC
SCHEDULE 13D Beneficial ownership report (>5%) October 8, 2025 View on SEC

IPO Filings

S-1 January 23, 2026
  • Pioneering AI-powered diagnostic platforms for early disease detection, with a flagship lung cancer detection system (Dx-100) in Phase 3 clinical trials.
  • Significant market opportunity in the global diagnostics market, projected to exceed $100 billion by 2030.
View Analysis

Annual Reports

10-K March 31, 2026
  • Developing high-speed, light-based data center connections to overcome AI bandwidth limitations.
  • Proprietary Gallium Nitride (GaN) integration allows for higher efficiency and heat tolerance than traditional silicon.
View Analysis

Related Companies

Companies in the same industry (SIC: 6770)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.